| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
| Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | | FI | | | Etoposid Sandoz 100 mg/5 ml | Durchstechflasche(n) à 100 mg | 21.70 | 40.00 | 10% | | Infusionskonzentrat: Etoposidum 100mg / 5ml | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | | FI | | | Etoposid Sandoz 1000
mg/50 ml | Durchstechflasche(n) à 1000 mg | 175.00 | 206.45 | 10% | | Infusionskonzentrat: Etoposidum 1000mg / 50ml | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | FI | | | Etopophos 113.6 mg | Durchstechflasche(n) | 40.09 | 60.00 | 10% | | Lyophilisat: Etoposidi Phosphas 113.6 mg | Cheplapharm Schweiz
GmbH | A / SL | FB | | G | |
| L | | FI | | | Etopophos 1136 mg | Durchstechflasche(n) | 364.57 | 412.90 | 10% | | Lyophilisat: Etoposidi Phosphas 1136.3 mg | Cheplapharm Schweiz
GmbH | A / SL | FB | | G | |
| | | FI | PI | | Vepesid 50 mg - T | 20 Kapsel(n) | 219.80 | 255.45 | 10% | | Kapseln: Etoposidum 50 mg | Cheplapharm Schweiz
GmbH | A / SL | FB | | G | |
| | | FI | PI | | Vepesid 100 mg | 10 Kapsel(n) | 219.80 | 255.45 | 10% | | Kapseln: Etoposidum 100 mg | Cheplapharm Schweiz
GmbH | ● A / SL | FB | | G | |
| | | FI | | | Etoposid Sandoz 400 mg/20 ml | Durchstechflasche(n) à 400 mg | 78.00 | 105.95 | k.A. | | Infusionskonzentrat: Etoposidum 400mg / 20ml | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | FI | | | Etoposide Pharmintraco 100 mg | Ampulle(n) | PA | PA | k.A. | | Infusionskonzentrat: Etoposidum 100mg / 5ml | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Etoposide Pharmintraco 500 mg | Ampulle(n) | PA | PA | k.A. | | Infusionskonzentrat: Etoposidum 500mg / 25ml | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Etoposide Pharmintraco 100 mg | 10 Ampulle(n) | PA | PA | k.A. | | Infusionskonzentrat: Etoposidum 100mg / 5ml | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Etoposide Pharmintraco
1000 mg | Ampulle(n) | PA | PA | k.A. | | Infusionskonzentrat: Etoposidum | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Etoposide Pharmintraco 500 mg | 10 Ampulle(n) | PA | PA | k.A. | | Infusionskonzentrat: Etoposidum 500mg / 25ml | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Etoposide Pharmintraco
1000 mg | 10 Ampulle(n) | PA | PA | k.A. | | Infusionskonzentrat: Etoposidum | Pharmintraco Sagl | A | FB | | G | |
|
| | | FI | | | Docetaxel Zentiva 20 mg/1 ml | | 48.36 | 69.00 | 10% | | Infusionskonzentrat: Docetaxelum 20 mg/ml | Helvepharm AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Zentiva 80 mg/4 ml | | 189.64 | 222.65 | 10% | | Infusionskonzentrat: Docetaxelum 80mg / 4ml | Helvepharm AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Zentiva 160
mg/8 ml | | 379.28 | 428.90 | 10% | | Infusionskonzentrat: Docetaxelum 160mg / 8ml | Helvepharm AG | A / SL / SG | FB | | G | |
| | | FI | | CM | Helvetaxel 20 mg/1 ml | | PA | PA | k.A. | | Infusionskonzentrat: Docetaxelum 20 mg/ml | Helvepharm AG | A | FB | | G | |
| | | FI | | CM | Helvetaxel 80 mg/4 ml | | PA | PA | k.A. | | Infusionskonzentrat: Docetaxelum 80mg / 4ml | Helvepharm AG | A | FB | | G | |
| | | FI | | | Taxotere 20 mg | Durchstechflasche(n) | 52.14 | 72.85 | 10% | | Infusionskonzentrat: Docetaxelum 20 mg/ml | Sanofi-Aventis
(Suisse) SA | A / SL / SO | FB | | G | |
| | | FI | | | Taxotere 80 mg | Durchstechflasche(n) | 208.59 | 242.10 | 10% | | Infusionskonzentrat: Docetaxelum 80mg / 4ml | Sanofi-Aventis
(Suisse) SA | A / SL / SO | FB | | G | |
| | | FI | | | Docetaxel Accord 20 mg/1 ml | | 47.41 | 68.00 | 10% | | Infusionskonzentrat: Docetaxelum 20 mg/ml | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Accord 80 mg/4 ml | | 189.64 | 222.65 | 10% | | Infusionskonzentrat: Docetaxelum 80mg / 4ml | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Accord 160 mg/8 ml | | 379.28 | 428.90 | 10% | | Infusionskonzentrat: Docetaxelum 160mg / 8ml | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Fresenius i.v. 80
mg/4 ml | Durchstechflasche(n) | 189.64 | 222.65 | 10% | | Infusionskonzentrat: Docetaxelum 80mg / 4ml | Fresenius Kabi
(Schweiz) AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Fresenius i.v. 160
mg/8 ml | Durchstechflasche(n) | 379.28 | 428.90 | 10% | | Infusionskonzentrat: Docetaxelum 160mg / 8ml | Fresenius Kabi
(Schweiz) AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Fresenius i.v. 20
mg/1 ml | Durchstechflasche(n) | 47.41 | 68.00 | 10% | | Infusionskonzentrat: Docetaxelum 20 mg/ml | Fresenius Kabi
(Schweiz) AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel-Teva liquid 20
mg/1 ml | | 48.37 | 69.00 | 10% | | Infusionskonzentrat: Docetaxelum 20 mg/ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel-Teva liquid 80
mg/4 ml | | 189.64 | 222.65 | 10% | | Infusionskonzentrat: Docetaxelum 80mg / 4ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel-Teva liquid 140
mg/7 ml | | 334.01 | 379.65 | 10% | | Infusionskonzentrat: Docetaxelum 140mg / 7ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| | | FI | | | Docetaxel Fresenius i.v. 120
mg/6 ml | Durchstechflasche(n) | 382.13 | 455.10 | k.A. | | Infusionskonzentrat: Docetaxelum 120mg / 6ml | Fresenius Kabi
(Schweiz) AG | A | FB | | G | |
| | | FI | | | Docetaxel Fresenius i.v. 180
mg/9 ml | Durchstechflasche(n) | 690.41 | 809.00 | k.A. | | Infusionskonzentrat: Docetaxelum 180mg / 9ml | Fresenius Kabi
(Schweiz) AG | A | FB | | G | |
|
| L | | FI | | | Cabazitaxel Labatec 60
mg/6 ml | | 2447.84 | 2690.90 | 10% | | Infusionskonzentrat: Cabazitaxelum 60mg / 6ml | Labatec Pharma SA | A / SL / SG | FB | | G | |
| L | | FI | | | Cabazitaxel Sandoz 60
mg/6 ml | | 2447.84 | 2690.90 | 10% | | Infusionskonzentrat: Cabazitaxelum 60 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| L | | FI | | | Cabazitaxel Viatris 60
mg/3 ml | | 2447.84 | 2690.90 | 10% | | Infusionskonzentrat: Cabazitaxelum 60mg / 3ml | Viatris Pharma GmbH | A / SL / SG | FB | | G | |
| | | FI | | | Cabazitaxel Labatec 45
mg/4.5 ml | | PA | PA | k.A. | | Infusionskonzentrat: Cabazitaxelum 45mg / 4.5ml | Labatec Pharma SA | A | FB | | G | |
| | | FI | | | Cabazitaxel Labatec 50
mg/5 ml | | PA | PA | k.A. | | Infusionskonzentrat: Cabazitaxelum 50mg / 5ml | Labatec Pharma SA | A | FB | | G | |
| | | FI | | | Cabazitaxel Sandoz 45
mg/4.5 ml | | PA | PA | k.A. | | Infusionskonzentrat: Cabazitaxelum 45 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| L | | FI | | PS | Jevtana 60 mg/1.5 ml | Durchstechflasche(n) | 2692.61 | 2942.05 | 10% | | solution à diluer et solvant pour solution pour perfusion: Cabazitaxelum 60 mg | Sanofi-Aventis
(Suisse) SA | A / SL / SO | FB | | G | |
| L | | FI | | | Cabazitaxel Accord 60
mg/3 ml | | 2447.84 | 2690.90 | 10% | | Infusionskonzentrat: Cabazitaxelum 60 mg | Accord Healthcare AG | A / SL / SG | FB | | G | |
| L | | FI | | | Cabazitaxel Spirig HC 60
mg/3 ml | 3 ml | 2447.84 | 2690.90 | 10% | | Infusionskonzentrat: Cabazitaxelum 60 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| L | | FI | | | Cabazitaxel-Teva 60 mg/6 ml | | 2447.84 | 2690.90 | 10% | | Infusionskonzentrat: Cabazitaxelum 60mg / 6ml | Teva Pharma AG | A / SL / SG | FB | | G | |
|
| | | FI | | | Campto 40 mg/2 ml | Durchstechflasche(n) | 44.51 | 64.40 | 40% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 40 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | FI | | | Campto 100 mg/5 ml | Durchstechflasche(n) | 107.78 | 132.65 | 40% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 100 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | FI | | | Campto 300 mg/15 ml | Durchstechflasche(n) | 288.99 | 328.05 | 40% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 300 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | FI | | | Irinotecan Accord 40 mg/2 ml | | 37.53 | 57.25 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Accord 100
mg/5 ml | | 90.97 | 115.40 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Accord 300
mg/15 ml | | 245.64 | 283.55 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml | Accord Healthcare AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Accord 500
mg/25 ml | | 357.73 | 405.70 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml | Accord Healthcare AG | ● A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Fresenius 40
mg/2 ml | | 37.83 | 57.55 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml | Fresenius Kabi
(Schweiz) AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Fresenius 100
mg/5 ml | | 91.81 | 116.25 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml | Fresenius Kabi
(Schweiz) AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Fresenius 300
mg/15 ml | | 245.64 | 283.55 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml | Fresenius Kabi
(Schweiz) AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Fresenius 500
mg/25 ml | | 368.46 | 416.70 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml | Fresenius Kabi
(Schweiz) AG | A / SL / SG | FB | | G | |
| | | FI | | CM | Irinotecan Sandoz eco 40
mg/2 ml | Durchstechflasche(n) | 37.85 | 57.60 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml | Sandoz
Pharmaceuticals AG | ● A / SL / SG | FB | | G | |
| | | FI | | CM | Irinotecan Sandoz eco 100
mg/5 ml | Durchstechflasche(n) | 91.81 | 116.25 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | FI | | CM | Irinotecan Sandoz eco 300
mg/15 ml | Durchstechflasche(n) | 245.64 | 283.55 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | FI | | CM | Irinotecan Sandoz eco 500
mg/25 ml | Durchstechflasche(n) | 362.42 | 410.50 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan-Teva liquid 40
mg/2 ml | | 38.11 | 57.85 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan-Teva liquid 100
mg/5 ml | | 91.42 | 115.85 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan-Teva liquid 500
mg/25 ml | | 357.73 | 405.70 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan-Teva liquid 300
mg/15 ml | | 245.64 | 283.55 | 10% | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| | | FI | | | Irinotecan Accord 1000
mg/50 ml | | PA | PA | k.A. | | Infusionskonzentrat: Irinotecani Hydrochloridum Trihydricum 1000mg / 50ml | Accord Healthcare AG | A | FB | | G | |
| | | FI | | PS | Onivyde liposomal pégylé 4.3
mg/ml | | PA | PA | k.A. | | dispersion à diluer pour perfusion: Irinotecanum 43mg / 10ml | Servier (Suisse) SA | A | FB | | G | |
|
| | | FI | PI | A | Iscador A 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Abietis) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador A 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Abietis) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador, A 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Abietis) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador, A 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Abietis) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador A 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Abietis) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador A 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Abietis) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador A 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 50 mg ex Viscum Album (Abietis) Recens 10 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador A 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 100 mg ex Viscum Album (Abietis) Recens 20 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Arg. 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Cu 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M c. Hg 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 0,0001 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.0005 mg ex Viscum Album (Mali) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 0,001 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.005 mg ex Viscum Album (Mali) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Mali) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Mali) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Mali) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Mali) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Mali) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M spezifiziert /
spécifié 1mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Mali) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Mali) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M spezifiziert /
spécifié 2mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 10 mg ex Viscum Album (Mali) Recens 2 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M spezifiziert /
spécifié 5mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 25 mg ex Viscum Album (Mali) Recens 5 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 50 mg ex Viscum Album (Mali) Recens 10 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador M 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 100 mg ex Viscum Album (Mali) Recens 20 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P c. Hg 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 0,0001 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.0005 mg ex Viscum Album (Pini) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 0,001 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.005 mg ex Viscum Album (Pini) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Pini) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Pini) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Pini) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Pini) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Pini) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Pini) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 50 mg ex Viscum Album (Pini) Recens 10 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador P 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 100 mg ex Viscum Album (Pini) Recens 20 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Arg. 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Cu 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu c. Hg 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 0,0001 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.0005 mg ex Viscum Album (Quercus) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 0,001 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.005 mg ex Viscum Album (Quercus) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Quercus) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.05 mg ex Viscum Album (Quercus) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Quercus) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 0.5 mg ex Viscum Album (Quercus) Recens | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Quercus) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu spezifiziert /
spécifié 1mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Quercus) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 5 mg ex Viscum Album (Quercus) Recens 1 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu spezifiziert /
spécifié 2mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 10 mg ex Viscum Album (Quercus) Recens 2 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu spezifiziert /
spécifié 5mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 25 mg ex Viscum Album (Quercus) Recens 5 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 50 mg ex Viscum Album (Quercus) Recens 10 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador Qu 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung: Extractum Aquosum Liquidum Fermentatum 100 mg ex Viscum Album (Quercus) Recens 20 mg/ml | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 0,01 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslsg anthrop. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 0,01 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslsg anthrop. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 0,1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung anthropos. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 1 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung anthropos. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 10 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung anthropos. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 20 mg | 7 | 37.40 | 57.10 | 10% | | Injektionslösung anthropos. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 0,1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung anthropos. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Iscador U c. Hg 1 mg | 2 x 7 | 74.69 | 97.65 | 10% | | Injektionslösung anthropos. Arzneimittel: 2 Wirkstoffe | Iscador AG | B / SL | FB | | G | |
| | | FI | PI | A | Helixor P 0,1 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthro. Arzneimittel: Extractum Aquosum Liquidum 2 mg ex Viscum Album (Pini) Recens | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 100 mg | 8 Ampulle(n) | 75.80 | 98.85 | 10% | | anthrop .Arzneimittel: Extractum Aquosum Liquidum 2 g ex Viscum Album (Abietis) Recens 100mg / 2ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 0,1 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 2 mg ex Viscum Album (Abietis) Recens | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 1 mg | 7 Ampulle(n) | 45.75 | 66.15 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Abietis) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 1 mg | 7 Ampulle(n) | 45.75 | 66.15 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Abietis) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 1 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Abietis) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 5 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 100 mg ex Viscum Album (Abietis) Recens 5 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 10 mg | 7 Ampulle(n) | 46.75 | 67.25 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 200 mg ex Viscum Album (Abietis) Recens 10 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 10 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 200 mg ex Viscum Album (Abietis) Recens 10 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 20 mg | 7 Ampulle(n) | 46.75 | 67.25 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 400 mg ex Viscum Album (Abietis) Recens 20 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 20 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 400 mg ex Viscum Album (Abietis) Recens 20 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 30 mg | 8 Ampulle(n) | 54.20 | 75.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 600 mg ex Viscum Album (Abietis) Recens 30 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 50 mg | 8 Ampulle(n) | 55.30 | 76.55 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 1 g ex Viscum Album (Abietis) Recens 50 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 0,1 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 2 mg ex Viscum Album (Mali) Recens | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 1 mg | 7 Ampulle(n) | 45.75 | 66.15 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Mali) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 1 mg | 7 Ampulle(n) | 45.75 | 66.15 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Mali) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 1 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Mali) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 5 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 100 mg ex Viscum Album (Mali) Recens 5 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 10 mg | 7 Ampulle(n) | 46.75 | 67.25 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 200 mg ex Viscum Album (Mali) Recens 10 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 10 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 200 mg ex Viscum Album (Mali) Recens 10 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 20 mg | 7 Ampulle(n) | 46.75 | 67.25 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 400 mg ex Viscum Album (Mali) Recens 20 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 20 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 400 mg ex Viscum Album (Mali) Recens 20 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 30 mg | 8 Ampulle(n) | 54.20 | 75.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 600 mg ex Viscum Album (Mali) Recens 30 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 50 mg | 8 Ampulle(n) | 55.30 | 76.55 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 1 g ex Viscum Album (Mali) Recens 50 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor M 100 mg | 8 Ampulle(n) | 75.80 | 98.85 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 2 g ex Viscum Album (Mali) Recens 100mg / 2ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 1 mg | 7 Ampulle(n) | 45.75 | 66.15 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Pini) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 1 mg | 7 Ampulle(n) | 45.75 | 66.15 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Pini) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 1 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 20 mg ex Viscum Album (Pini) Recens 1 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 5 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 100 mg ex Viscum Album (Pini) Recens 5 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 10 mg | 7 Ampulle(n) | 46.75 | 67.25 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 200 mg ex Viscum Album (Pini) Recens 10 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 10 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 200 mg ex Viscum Album (Pini) Recens 10 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 20 mg | 7 Ampulle(n) | 46.75 | 67.25 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 400 mg ex Viscum Album (Pini) Recens 20 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 20 mg | 8 Ampulle(n) | 50.50 | 71.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 400 mg ex Viscum Album (Pini) Recens 20 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 30 mg | 8 Ampulle(n) | 54.20 | 75.35 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 600 mg ex Viscum Album (Pini) Recens 30 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 50 mg | 8 Ampulle(n) | 55.30 | 76.55 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 1 g ex Viscum Album (Pini) Recens 50 mg/ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor P 100 mg | 8 Ampulle(n) | 75.80 | 98.85 | 10% | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 2 g ex Viscum Album (Pini) Recens 100mg / 2ml | Target BioScience AG | A / SL | FB | | G | |
| | | FI | PI | A | Helixor A 0,01 mg | 8 Ampulle(n) | 50.50 | 74.35 | k.A. | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 0.2 mg ex Viscum Album (Abietis) Recens | Target BioScience AG | A | FB | | G | |
| | | FI | PI | A | Helixor M 0,01 mg | 8 Ampulle(n) | 50.50 | 74.35 | k.A. | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 0.2 mg ex Viscum Album (Mali) Recens | Target BioScience AG | A | FB | | G | |
| | | FI | PI | A | Helixor P 0,01 mg | 8 Ampulle(n) | 50.50 | 74.35 | k.A. | | anthrop. Arzneimittel: Extractum Aquosum Liquidum 0.2 mg ex Viscum Album (Pini) Recens | Target BioScience AG | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini 0,02 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini 0,2 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini 2 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini 20 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini D6 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D6 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini D10 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D10 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini D20 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D20 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | abnobaVISCUM Fraxini D30 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D30 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
